Target intelligence / Profile preview

Serine hydrolase superfamily (SH)

Target
SH
Molecular classification
Enzyme, Serine hydrolase, Protease
01

Overview

The serine hydrolase superfamily is one of the largest and most diverse enzyme classes in mammals, comprising over 200 members including proteases, lipases, esterases, and thioesterases. These enzymes are characterized by a conserved catalytic mechanism involving a nucleophilic serine residue, often found within a Gly-X-Ser-X-Gly consensus motif, which forms a covalent acyl-enzyme intermediate with substrates. They play critical roles in virtually every physiological process, from blood coagulation and digestion to neurotransmission and immune response. Due to their central roles in health and disease, serine hydrolases are major therapeutic targets for conditions such as diabetes (DPP-4 inhibitors), obesity (lipase inhibitors), and Alzheimer's disease (acetylcholinesterase inhibitors). However, the structural similarity across the superfamily poses significant challenges for achieving drug selectivity and avoiding off-target safety concerns.

Other names
Serine-dependent enzymesSerine proteasesSerine esterasesSerine lipasesSerine-dependent hydrolases
02

Mechanism of action

Inhibition of the nucleophilic serine residue within the catalytic triad (typically Ser-His-Asp) of the enzyme's active site, often through covalent modification (e.g., phosphorylation by organophosphates or carbamylation by carbamates).

03

Biological functions

ProteolysisLipid metabolismSignal transductionNeurotransmissionBlood coagulation
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseInfection
05

Safety considerations

Cholinergic crisis (for acetylcholinesterase inhibitors)Bleeding risk (for anticoagulants)Off-target toxicity due to the broad nature of the superfamily
06

Interacting drugs

Diisopropyl fluorophosphate

8 more in the full profile.

07

Biomarkers

Cholinesterase activityD-dimer (for thrombin activity)Prothrombin time (PT)

Beyond the preview

Go deeper on Serine hydrolase superfamily (SH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine hydrolase superfamily (SH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call